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Summary A 26-year-old pregnant woman who was an intravenous drug user
(IDU) was admitted to our hospital for the treatment of tricuspid valve infective
endocarditis (IE) and lung abscesses due to methicillin-resistant Staphylococcus
aureus (MRSA). We started to treat her with vancomycin (VCM) alone and then in
combination with rifampicin (RFP), but her condition did not improve. Then we
added sulfamethoxazole/trimethoprim (SMZ/TMP) to VCM and RFP. After that, she
improved rapidly. In Japan, there are very few reports about tricuspid valve IE caused
by MRSA in IDUs. This case suggests that the combination of VCM, RFP, and SMZ/TMP
may be effective for the treatment of severe MRSA infections.
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Introduction
Vancomycin (VCM) is a drug of ﬁrst choice in the
treatment of methicillin-resistant Staphylococcus
aureus (MRSA) infections, but it has a high rate
of treatment failure. Combination therapy may
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e considered in selected invasive MRSA infec-
ions refractory to standard VCM monotherapy. We
resent a case of MRSA tricuspid valve (TV) infec-
ive endocarditis (IE) with multiple embolic lung
bscesses, in which the addition of sulfamethox-
zole/trimethoprim (SMZ/TMP) to the combination
f VCM and rifampicin (RFP) was effective.ase history
26-year-old woman who was an intravenous drug
ser (IDU) was admitted to another hospital for the
gy. Published by Elsevier Ireland Ltd. All rights reserved.
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vRSA tricuspid valve infective endocarditis with mu
reatment of TV IE caused by methicillin-sensitive
taphylococcus aureus. She was discharged after
weeks of treatment with penicillin G (2 million
nits/day), but she did not stop being an IDU after
hat. Four months later, she became pregnant. Ten
onths later, 3 days before admission to our hos-
ital, she suffered from fever (>38 ◦C) and cough.
eneral fatigue and back pain also developed and
he was admitted to the obstetrical department of
ur hospital.
Her blood pressure was 100/60mmHg, heart rate
as 105min−1 and SpO2 under room-air condition
as 98%. Many marks of intravenous drug injection
xisted on her hands. She had no peripheral mani-
estations of IE, such as petechiae, Roth spot, and
sler node. Levine 2/6 systolic regurgitant murmur
t
C
c
V
igure 1 Two-dimensional echocardiogram (Day 5) revealing
alve and moderate tricuspid valve regurgitation.le embolic lung abscesses 147
as audible at 4th left intercostal space. She had
oarse crackles in both sides of the chest.
Abnormal laboratory ﬁndings were white blood
ell count 12,200l (neutrophils 92%), hemoglobin
.8mg/dl, C-reactive protein 12.7mg/dl, and pos-
tive hepatitis C virus antibody. Echocardiography
evealed vegetation (3 mm× 7mm) on the anterior
V and anterior TV prolapse with loss of coaptation
nd with moderate TV regurgitation (peak velocity:
00.3 cm/s), and enlarged right atrium and ventri-
le (4 chamber view, RV: 55mm, Fig. 1). Chest X-ray
nd chest computed tomography (CT) showed mul-
iple lung abscesses and pleural effusion (Fig. 2).
ardiac shadow was enlarged. Blood and sputum
ulture revealed MRSA, which were sensitive to
CM, RFP, and SMZ/TMP. She was referred to the
vegetation (white arrow: 3mm× 7mm) on the tricuspid
148 T. Fujino et al.
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rFigure 2 Chest X-ray (Day 7) and chest CT (Day 8)
department of cardiology for the treatment of IE
andmultiple embolic lung abscesses after emergent
Caesarean section.
We started VCM 1.5 g/day (30mg/kg) in two
equally divided doses (Fig. 3). Her symptoms and
laboratory data did not improve 5 days after treat-
ment. We increased VCM dose (3 g/day in two
equally divided doses) because of low VCM trough
and peak concentrations (4g/ml and 19g/ml)
and added RFP (600mg/day). We considered
to maintain VCM trough concentrations ranging
15—20g/ml and peak concentrations ranging
30—45g/ml in order to keep efﬁcacy and prevent
toxicity. Nine days after this conventional combi-
nation treatment for MRSA IE, her clinical ﬁndings
did not improve and her VCM trough concentrations
were still low (9.0g/ml). Therefore, we increased
dosages of VCM (4.0 g/day in two equally divided
doses) and RFP (900mg/day). Twelve days after
m
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Figure 3 Clinical course after initiation of treatment. AD, adaling multiple lung abscesses and pleural effusion.
reatment, although her blood culture was nega-
ive for the ﬁrst time, VCM trough concentrations
ncreased to 59g/ml. Her renal function worsened
nd red man syndrome appeared. We stopped VCM
ransiently for 3 days and added SMZ/TMP (4 g/day)
o RFP. Her symptoms, blood tests, and imaging
ests improved rapidly. Sixteen days after treat-
ent we started VCM (1.5 g/day in two equally
ivided doses) again. Vegetation of TV disappeared
9 days after treatment and the size of right atrium
nd ventricle decreased (apical 4 chamber view,
V: 39mm), probably because of decreased circu-
ating volume after delivery and improved heart
ailure. Echocardiography also revealed the ante-
ior TV prolapse with partial loss of coaptation and
ild TV regurgitant ﬂow (peak velocity: 230 cm/s).
ultiple lung abscesses disappeared 54 days after
reatment by chest CT. She was discharged without
omplications.
mission; BT, body temperature; Cre, serum creatinine.
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[8] Yamaoka T. The bactericidal effects of anti-MRSA agents
with rifampicin and sulfamethoxazole-trimethoprim againstRSA tricuspid valve infective endocarditis with mu
iscussion
n the USA, the vast majority of right-sided IE occur
n IDUs and a majority of IDUs with IE have right-
ided infections, in which TV is infected in more
han 50% [1]. In IDUs the valves were normal before
nfection in 75—93% of patients [2]. Injection of
llicit drugs may produce transient or permanent
ndothelial damage of the TV, and non-bacterial
hrombus may occur on the damaged valve and be
nfected by the pathogens which are usually orig-
nated from the skin, explaining the predominance
f Staphylococcus aureus [2]. Still more, the low
ressure gradient between the right ventricle and
ight atrium may be responsible for the absence of
murmur with TV IE [3]. Septic pulmonary emboli
re present in 87% of TV infections particularly
aused by S. aureus [4]. In Japan, right-sided IE
sually occurs on the predisposing structural TV
esions accompanied by congenital heart disease,
nd cases of TV IE in IDUs are rare. Only 7 IDU
ases were reported from 1985 to 2000 [5] and
ne case was caused by MRSA, but it is increasing
wing to the increase in IDUs. Even in Japan we
hould pay attention to the possibility of TV IE
ithout predisposing structural valve disease. Our
atient was an IDU pregnant woman and had TV
E with multiple embolic lung abscesses caused by
RSA. Hyperkinetic circulation and dilation of TV
nnulus during pregnancy might be associated with
n increase in TV regurgitation and a detectable
urmur due to anterior TV prolapse [6].
Although VCM is a drug of ﬁrst choice in the
reatment of MRSA infection [4], VCM has slow
linical response and unacceptably high rate of
reatment failure. Regarding right-sided IE caused
y either MSSA or MRSA, VCM was reported to
e less effective because of limited bactericidal
ctivity, poor penetration into vegetations, and
ncreased drug clearance among IDUs [4]. The MRSA
train of our patient was sensitive to old agents
uch as RFP and SMZ/TMP. Most staphylococci have
igh susceptibility to RFP, but RFP has been sug-
ested as adjunctive therapy in patients who do
ot respond adequately to conventional antimi-
robial therapy [4,7], because resistance develops
apidly when this agent is used alone. SMZ/TMP
as reported to be a useful alternative to VCM
or treatment of MRSA infections in IDUs, but clin-
cal experience with this agent for MRSA IE is
imited [4]. Some reports suggest that the com-
[
Available online at www.le embolic lung abscesses 149
ination of VCM, RFP, and SMZ/TMP is effective
or severe MRSA infections, which were refractory
o VCM monotherapy [8]. These include infections
uch as IE, meningitis, and prosthetic device infec-
ions [9]. Our patient had recurrent MRSA IE and
ultiple lung abscesses to which VCM had poor pen-
tration. Therefore, recommended values of both
CM trough and peak concentrations were higher
han usual. We administered only VCM as an ini-
ial therapy and then added RFP together with the
ncrease in VCM dose, but the condition of the
atient did not improve. We decided the addition
f SMZ/TMP to the combination of VCM and RFP,
hich was highly effective to control the infec-
ion.
We conclude that for refractory MRSA IE the
ombination of VCM, RFP, and SMZ/TMP should be
onsidered and that right-sided IE of IDUs should be
emembered even in Japan.
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